We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Stay up to date on the topics that matter to you

Image of Alison Halliday, PhD

Alison Halliday, PhD

Dr. Alison Halliday is an award-winning freelance science communications specialist with 20+ years of experience across academia, industry and the third sector – including ten years at the world’s largest cancer charity. She is skilled at translating complex information into jargon-free, engaging, stories – specializing in topics across the life sciences, medicine and health. After completing her PhD in molecular genetics at the University of Newcastle, she carried out five years of postdoctoral research at University College London before moving into science communications. She now works with a variety of clients to bring their research to life – including companies that need support with their product marketing, or organizations looking to engage with their audiences about the latest advances in biomedicine.

Latest Content

Advances in Medicinal Chemistry content piece image

Advances in Medicinal Chemistry

Medicinal chemists play a crucial role in drug discovery through the selection, synthesis and testing of a myriad of compounds. Recent advances in technologies are set to accelerate their progress.

The Importance of Diagnostics in Tackling the COVID-19 Pandemic content piece image

The Importance of Diagnostics in Tackling the COVID-19 Pandemic

Large-scale testing and contact tracing are central to efforts to control the pandemic. This relies on diagnostic tests that can rapidly, accurately and reliably detect SARS-CoV-2.

Sequencing the Human Microbiome: Opening the Black Box content piece image

Sequencing the Human Microbiome: Opening the Black Box

Researchers are using sequencing technologies to rapidly expand our knowledge of the human microbiome and identify undiscovered bacterial genomes.

The Therapeutic Antibody Revolution content piece image

The Therapeutic Antibody Revolution

A crucial component of our immune system, antibodies are now the most rapidly growing class of approved biopharmaceutical drugs. We explore the past, present and future of therapeutic monoclonal antibodies.

Cancer Biomarkers: Powering Precision Medicine content piece image

Cancer Biomarkers: Powering Precision Medicine

Researchers are developing biomarker tests to detect cancer early, monitor therapeutic efficacy and predict outcomes – making diagnosis and treatment more precise.

Lipidomics – A Niche but Rapidly Growing Field content piece image

Lipidomics – A Niche but Rapidly Growing Field

Although researchers have been working on lipid biochemistry for many decades, lipidomics is a more recent, newly emerging discipline – with potential applications for diagnosing and preventing disease.

Uncovering the Secrets of the Breast Cancer Epigenome content piece image

Uncovering the Secrets of the Breast Cancer Epigenome

The epigenome plays a crucial role in the development of breast cancer. This exciting and rapidly evolving area of research holds great promise for new interventions – from prevention through to personalized treatment.

Targeting TGF-β Signaling in Cancer: A Double-edged Sword content piece image

Targeting TGF-β Signaling in Cancer: A Double-edged Sword

Transforming growth factor (TGF)-β signaling is an attractive therapeutic target as it is deregulated in many cancers. But challenges remain around developing inhibitors that can specifically block tumor-promoting activities while preserving its tumor suppressive effects.

A female scientist.

A Renaissance for Microflow Liquid Chromatography Mass Spectrometry?

First developed in the 1970s, recent developments are making microflow liquid chromatography techniques more robust – enticing researchers to revisit the opportunities it offers for more sensitive, high-throughput analyses requiring smaller sample volumes than standard flow techniques.

Exploiting Epigenetics in Cancer Treatment content piece image

Exploiting Epigenetics in Cancer Treatment

Changes to the complex of DNA and the proteins that form chromatin are important drivers in many cancers. We explore the challenges and progress in the development of new therapies targeting epigenetic regulators.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter